CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3102-3109

  Faunce, Douglas E ^a,b   Palmer, Jessica L ^a   Paskowicz, Kelly K ^a   Witte, Pamela L ^a,b   Kovacs, Elizabeth J ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD1D ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; MONOCLONAL ANTIBODY;

AGE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR IMMUNITY;

EID: 23844518317     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3102     Document Type: Article

References (44)

1. Solana, R., and G. Pawelec. 1998. Molecular and cellular basis of immunosenescence. Mech. Ageing Dev. 102: 115-129.
2. Johnson, K. M., K. Owen, and P. L. Witte. 2002. Aging and developmental transitions in the B cell lineage. Int. Immunol. 14: 1313-1323.
3. Stephan, R. P., V. M. Sanders, and P. L. Witte. 1996. Stage-specific alterations in murine B lymphopoiesis with age. Int. Immunol. 8: 509-518.
4. Globerson, A., and R. B. Effros. 2000. Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today 21: 515-521.
5. Linton, P. J., and K. Dorshkind. 2004. Age-related changes in lymphocyte development and function. Nat. Immunol. 5: 133-139.
6. Thoman, M. L. 1995. The pattern of T lymphocyte differentiation is altered during thymic involution. Mech. Ageing Dev. 82: 155-170.
7. Gillis, S., R. Kozak, M. Durante, and M. E. Weksler. 1981. Immunological studies of aging: decreased production of and response to T cell growth factor by lymphocytes of aged humans. J. Clin. Invest. 67: 937-942.
8. Huang, Y. P., J. C. Pechere, M. Michel, L. Cauthey, M. Loreto, J. A. Currant, and J. P. Michel. 1992. In vivo T cell activation, in vitro defective 1L-2 secretion, and response to influenza vaccination in elderly women. J. Immunol. 148: 715-722.
9. + lymphocytes in the aged microenvironment results in a memory-enriched population. J. Immunol. 162: 711-717.
10. Wikby, A., P. Maxson, J. Olsson, B. Johansson, and F. G. Ferguson. 1998. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 102: 187-198.
11. Ouyang, Q., G. Cickek, R. G. J. Westendorp, H. J. M. Cools, R.-J. van der Klis, and E. J. Remarque. 2000. Reduced IFNγ production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech. Ageing Dev. 121: 131-137.
12. Garcia, G. G., and R. A. Miller. 2001. Single-cell analyses reveal two defects in peptide-specific activation of naive T cells from aged mice. J. Immunol. 166: 3151-3157.
13. Miller, R. A. 2000. Effect of aging on T lymphocyte activation. Vaccine 18: 1654-1660.
14. Pawelec, G., K. Hirokawa, and T. Fulop. 2001. Altered T cell signaling in ageing. Mech. Ageing Dev. 122: 1613-1637.
15. Tarazona, R., O. DelaRosa, C. Alonso, B. Oslos, J. Espejo, J. Pena, and R. Solana. 2000. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121: 77-88.
16. + T cells in vitro and their possible role in age-associated changes in inducible IL-4 production. Cell. Immunol. 179: 22-29.
17. Mocchegiani, E., and M. Malavolta. 2004. NK and NKT cell functions in immunosenescence. Aging Cell 3: 177-184.
18. Osman, Y., T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, and T. Abo. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30: 1919-1928.
19. Tsukahara, A., S. Seki, T. Iiai, T. Moroda, H. Wantanabe, S. Suzuki, T. Tada, H. Hiraide, K. Hatakeyama, and T. Abo. 1997. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 26: 301-309.
20. Faunce, D. E., K. H. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166: 313-321.
21. Faunce, D. E., R. L. Gamelli, and E. J. Kovacs. 2003. A role for CD1d-NKT cells in injury-associated T cell suppression. J. Leukocyte Biol. 73: 747-755.
22. + T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169: 31-38.
23. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
24. Coles, M. C., C. W. McMahon, H. Takizawa, and D. H. Raulet. 2000. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 30: 236-244.
25. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32: 848-857.
26. Sonoda, K. H., M. A. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190: 1215-1226.
27. Sonoda, K. H., D. E. Faunce, M. Taniguchi, M. A. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166: 42-50.
28. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
29. Martin, E., B. O'Sullivan, P. Low, and R. Thomas. 2003. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18: 155-167.
30. Mocellin, S., M. C. Panelli, E. Wang, D. Nagorsen, and F. M. Marincola. 2003. The dual role of IL-10. Trends Immunol. 24: 36-43.
31. Solana, R., and E. Mariani. 2000. NK and NK/T cells in human senescence. 18: 1613-1620.
32. Linton, P., and M. L. Thoman. 2001. T cell senescence. Front. Biosci. 6: D248-D261.
33. LeMaoult, J., I. Messaoudi, J. S. Manavalan, H. Potvin, D. Nikolich-Zugich, R. Dyall, P. Szabo, M. E. Weksler, and J. Nikolich-Zugich. 2000. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J. Immunol. 165: 2367-2373.
34. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
35. Joyce, S. 2001. CD1d and natural T cells: how their properties jump-start the immune system. Cell. Mol. Life Sci. 58: 442-469.
36. Exley, M. A., N. J. Bigley, O. Cheng, S. M. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, and S. P. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. [Published erratum in 2001 J. Leukocyte Biol. 70: 340.] J. Leukocyte Biol. 69: 713-718.
37. Haynes, L., S. M. Eaton, E. M. Burns, M. Rincon, and S. L. Swain. 2004. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J. Immunol. 172: 5194-5199.
38. + T cells produce large amounts of IL-4 and IFNγ upon activation by anti-CD3 or CD1. J. Immunol. 159: 2240-2249.
39. Terabe, M., S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D. D. Donaldson, D. P. Carbone, W. E. Paul, and J. A. Berzofsky. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1: 515-520.
40. Colgan, S. P., R. M. Hershberg, G. T. Furuta, and R. S. Blumberg. 1999. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 96: 13938-13943.
41. Tahir, S. M., O. Cheng, A. Shaulov, Y. Koeruka, G. J. Bubley, S. B. Wilson, S. P. Balk, and M. A. Exley. 2001. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167: 4046-4050.
42. Nieuwenhuis, E. E., T. Matsumoto, M. A. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593.
43. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1801-1811.
44. Zhang, B., T. Yamamura, T. Konodo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encepahlomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.